Clover Biopharmaceuticals Email Format
Biotechnology ResearchShanghai, China51-200 Employees
Clover Biopharmaceuticals is a global biotechnology company focused on vaccines, integrating research and development, manufacturing, and commercial capabilities to bring candidates to market. It aims to reduce the burden of vaccine-preventable diseases and expand preventive options, maintaining partnerships worldwide and prioritizing equitable access. Founded in 2007 and based in Shanghai, China, the company operates in a global health context. In the biotechnology research industry, Clover collaborates with partners to advance its diverse vaccine pipeline toward potential health impact. In October 2025, the company named Dr. Nicholas Jackson as President of Global R&D and Alliances, highlighting a leadership emphasis on global development and collaborative initiatives.